Biogen Inc (NASDAQ:BIIB)

404.63
Delayed Data
As of Jul 06
 +0.35 / +0.09%
Today’s Change
290.85
Today|||52-Week Range
480.18
+19.20%
Year-to-Date

Today’s Trading

Previous close404.28
Today’s open399.86
Day’s range-- - --
Volume1,189,697
Average volume (3 months)1,554,030
Market cap$95.1B
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+20.74%
Earnings growth (next 5 years)+14.60%
Revenue growth (last year)+39.61%
P/E ratio29.2
Price/Sales8.30
Price/Book8.77

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+1.24+0.81%
GILDGilead Sciences+0.62+0.54%
BXLTBaxalta Inc+0.68+2.19%
BAXBaxter International...-0.26-0.68%
Data as of 07/06/2015

Financials

Next reporting dateJuly 21, 2015
EPS forecast (this quarter)$4.06
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers